ABIONYX Pharma SA logo

ABIONYX Pharma SA

EPA:ABNX.PA

Overview | Financials
Company Name ABIONYX Pharma SA
Symbol ABNX.PA
Currency EUR
Price 1.348
Market Cap 46,744,693
Dividend Yield 0%
52-week-range 0.91 - 1.5
Industry Biotechnology
Sector Healthcare
CEO Sir Cyrille Tupin CPA
Website https://abionyx.com

An error occurred while fetching data.

About ABIONYX Pharma SA

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. The company is developing CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural

Related Stocks

Crossject Société Anonyme logo

Crossject Société Anonyme

ALCJ.PA

2.15 EUR

Visiomed Group SA logo

Visiomed Group SA

ALVMG.PA

0.173 EUR

Poxel S.A. logo

Poxel S.A.

POXEL.PA

0.267 EUR

Valbiotis SA logo

Valbiotis SA

ALVAL.PA

1.184 EUR

Celyad Oncology SA logo

Celyad Oncology SA

CYAD.BR

0.667 EUR

Adocia SA logo

Adocia SA

ADOC.PA

9.1 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD